Lafayette Jury Awards $9 Billion in Punitive Damages
A jury in Lafayette has awarded $1.5 million in compensatory damages and $9 billion in punitive damages to a former user of the Actos diabetes medication after the jury determined that the drug was linked to the plaintiff’s bladder cancer. Both defendants, Takeda Pharmaceuticals Co. and Eli Lilly & Co., insists that their medication is safe and they plan to appeal the jury’s verdict. The plaintiff began taking Actos in 2006 to treat his Type 2 diabetes until 2011, when the U.S. Food and Drug Administration placed a warning on the medication’s labels stating that use of the drug for more than a year increases the risk of bladder cancer. The trial also featured Takeda officials destroying pertinent documents about the development and marketing of Actos, which prompted sanctions from U.S. District Judge Rebecca Doherty.